SPY386.54-3.04 -0.78%
DIA314.19-1.40 -0.44%
IXIC13,358.79-230.04 -1.69%

DJ Shanghai Henlius Biotech May Emerge as Innovative Market Leader -- Market Talk

· 02/04/2021 23:04

0404 GMT - Shanghai Henlius Biotech could emerge as an innovative market leader due to its diverse product offerings, UOB Kay Hian says. It initiates coverage of the stock with a buy rating and HK$56.00 target price, as it expects the company's new biosimilar products to boost revenue growth to 102% CAGR over 2020-22. Henlius is also entering the global market faster than most of its peers. The brokerage sees a growth opportunity in China's biologics market, which it expects to expand at a CAGR of 18.0% over 2019-24. Shares are down 1.5% to HK$39.00. (yiwei.wong@wsj.com)

(END) Dow Jones Newswires

February 04, 2021 23:04 ET (04:04 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.